EUVIMEDEUVIMED entdecken
Crossref

Dantrolene Protects Hippocampal Neurons Against Amyloid-β₁₋₄₂-Induced Calcium Dysregulation and Cell Death

Nataliia M Rozumna, Vita V Hanzha, Vyacheslav M Shkryl, Elena A Lukyanetz

Neurochemical Research · 2025

DOI: 10.1007/s11064-025-04460-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Nataliia M Rozumna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine. Hauptthemen laut MEDLINE: Dantrolene, Hippocampus, Neurons, Amyloid beta-Peptides. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accumulation of amyloid-β₁₋₄₂ (Aβ₁₋₄₂) in the brain is a hallmark of Alzheimer's disease (AD), contributing to intracellular calcium dysregulation and neuronal death. Ryanodine receptors (RyRs), located in the endoplasmic reticulum (ER), play a pivotal role in intracellular calcium release and homeostasis. In this study, we employed an in vitro model of AD using cultured rat hippocampal neurons treated with Aβ₁₋₄₂ to investigate the effects of dantrolene, a RyR antagonist, on calcium signaling and neuronal viability. Dantrolene significantly reduced basal cytosolic calcium levels and attenuated stimulus-induced calcium transients in response to depolarizing solution, electrical field stimulation, and caffeine application. These findings indicate that dantrolene stabilizes intracellular calcium signaling by limiting calcium release from ER stores. Furthermore, co-application of dantrolene with Aβ₁₋₄₂ increased neuronal survival from 26 to 76% and significantly reduced the proportions of apoptotic and necrotic cells. These results demonstrate that RyRs contribute to calcium overload and neurotoxicity under AD-like conditions and that dantrolene effectively counteracts Aβ₁₋₄₂-induced calcium dysregulation. Altogether, our findings support the calcium hypothesis of AD and highlight dantrolene as a potential disease-modifying agent targeting ER-mediated calcium homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DantroleneHippocampusNeuronsAmyloid beta-PeptidesCalciumPeptide FragmentsNeuroprotective AgentsAnimalsCell DeathRatsCells, CulturedCell SurvivalRats, Sprague-DawleyRyanodine Receptor Calcium Release ChannelCalcium Signaling

Stichwörter der Autor:innen

Alzheimer's diseaseAmyloid betaCalciumCell viabilityDantroleneEndoplasmic reticulumHippocampal neuronsIntracellular calcium homeostasisNeuroprotectionRyanodine receptors

Substanzen

DantroleneAmyloid beta-PeptidesCalciumPeptide FragmentsNeuroprotective Agentsamyloid beta-protein (1-42)Ryanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
  • Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine. slava@biph.kiev.ua.
  • Department Biophysics of Ion Channels, Bogomoletz Institute of Physiology, Bogomoletz Str.,4, Kyiv-24, Kyiv, 01024, Ukraine. slava@biph.kiev.ua.

Zitieren

APA

Rozumna, N. M., Hanzha, V. V., Shkryl, V. M., & Lukyanetz, E. A. (2025). Dantrolene Protects Hippocampal Neurons Against Amyloid-β₁₋₄₂-Induced Calcium Dysregulation and Cell Death. Neurochemical Research. https://doi.org/10.1007/s11064-025-04460-5

Vancouver

Rozumna NM, Hanzha VV, Shkryl VM, Lukyanetz EA. Dantrolene Protects Hippocampal Neurons Against Amyloid-β₁₋₄₂-Induced Calcium Dysregulation and Cell Death. Neurochemical Research. 2025. doi:10.1007/s11064-025-04460-5

BibTeX
@article{Rozumna2025,
  author = {Rozumna, Nataliia M and Hanzha, Vita V and Shkryl, Vyacheslav M and Lukyanetz, Elena A},
  title = {Dantrolene Protects Hippocampal Neurons Against Amyloid-β₁₋₄₂-Induced Calcium Dysregulation and Cell Death},
  journal = {Neurochemical Research},
  year = {2025},
  doi = {10.1007/s11064-025-04460-5}
}
Kostenlos starten →